Oakley Capital Acquires Majority Stake in vitroconnect

Oakley Capital Fund IV and CVC Growth Acquire Majority Stake in TechInsights

December 15, 2021

Data & Analytics

Oakley Capital Fund III has agreed to sell its stake in TechInsights, with Oakley Capital Fund IV acquiring a majority stake alongside CVC Growth Funds. The transaction provides an exit for Fund III while delivering follow-on investment to support TechInsights' shift to subscription revenues and a multi-year expansion programme under CEO Gavin Carter.

Oakley Capital Invests in ProductLife Group

May 28, 2024

Pharmaceuticals

Oakley Capital Fund V is investing in ProductLife Group, a European provider of outsourced development, regulatory and compliance services to the life sciences industry. Oakley will partner with management and reinvesting shareholder 21 Invest to support international expansion, accelerate AI-driven technology enablement, and pursue a buy-and-build strategy.

Oakley Capital Origin Fund Invests in Vice Golf (Vice Sporting Goods GmbH)

May 6, 2022

Consumer Products

Oakley Capital Origin Fund is investing in Vice Sporting Goods GmbH (trading as Vice Golf), a digitally-native Munich-based golf brand known for DTC premium golf balls and accessories. The investment will support Vice Golf's international expansion, product diversification (including apparel collaborations) and acceleration of its direct-to-consumer growth.

Oakley Capital Origin Fund I Acquires Majority Stake in Horizons Optical

March 18, 2024

Medical Devices

Oakley Capital Origin Fund I is acquiring a majority stake in Horizons Optical from Sherpa Capital, with CEO Santiago Soler retaining a significant share and remaining CEO. Horizons, founded in Barcelona in 2017, provides proprietary medical software and scanning equipment used by independent laboratories and opticians to manufacture premium bespoke spectacle lenses; Oakley will support international expansion and R&D, and invest in Sales & Marketing to accelerate growth.

BroadOak Capital Partners Invests Growth Capital in PhenoVista Biosciences

January 18, 2022

Biotechnology

PhenoVista Biosciences, a San Diego–based provider of high-content, imaging-based phenotypic assay services, raised growth capital from BroadOak Capital Partners. The funding will be used to accelerate development of complex biological models (e.g., blood–brain barrier, neurodegenerative disease platforms) and expand PhenoVista's assay and data-analysis capabilities.

Oakley Capital Acquires Majority Stake in Seven Miles

August 25, 2019

Retail

Oakley Capital has agreed to acquire a majority stake in Seven Miles GmbH, a German consumer-technology business operating multi-brand gift voucher platforms including Wunschgutschein and WishCard. Oakley will partner with founders Tom Schröder and Valentin Schütt to accelerate the company’s digital platform, product innovation and DACH growth; Seven Miles connects over 500 brands and 60,000 points of sale and reported gift solution sales in excess of €100m in 2019.